Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06954025
PHASE2

High-Intensity Inpatient MDMA-Assisted Psychotherapy for PTSD

Sponsor: ARQ National Psychotrauma Centre

View on ClinicalTrials.gov

Summary

This study will evaluate the feasibility, safety and efficacy of high-intensity inpatient MDMA-assisted psychotherapy for treatment-refractory posttraumatic stress disorder.

Official title: High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-05-16

Completion Date

2027-01

Last Updated

2025-07-24

Healthy Volunteers

No

Interventions

DRUG

High-intensity inpatient MDMA-assisted psychotherapy

Drug: 3,4-methylenedioxymethamphetamine (MDMA) Session 1: 80 mg MDMA HCl followed by a supplemental dose of 40 mg Session 2: 120 mg MDMA HCl followed by a supplemental dose of 60 mg Psychotherapy: manualized psychotherapy

Locations (1)

ARQ National Psychotrauma Centre / ARQ Centrum'45

Oegstgeest, Netherlands